1. Home
  2. THH vs COCP Comparison

THH vs COCP Comparison

Compare THH & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

THH

TryHard Holdings Limited Ordinary Shares

N/A

Current Price

$0.39

Market Cap

17.1M

Sector

N/A

ML Signal

N/A

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.25

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THH
COCP
Founded
2013
2006
Country
Japan
United States
Employees
116
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1M
15.6M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
THH
COCP
Price
$0.39
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
924.9K
4.2M
Earning Date
05-19-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.65
EPS
N/A
N/A
Revenue
N/A
$12,712,091.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$305.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.86
52 Week High
$56.26
$2.19

Technical Indicators

Market Signals
Indicator
THH
COCP
Relative Strength Index (RSI) 40.78 55.17
Support Level $0.31 $0.95
Resistance Level $0.55 $1.42
Average True Range (ATR) 0.05 0.15
MACD 0.12 0.03
Stochastic Oscillator 36.81 25.25

Price Performance

Historical Comparison
THH
COCP

About THH TryHard Holdings Limited Ordinary Shares

Tryhard Holdings Ltd is a Japan-based lifestyle entertainment company offering services across the entertainment and hospitality sectors. Its main businesses include event curation, consultancy and management, sub-leasing of venues, and restaurant operations. The company operates through four segments, with the majority of revenue generated from consultancy and management, which provides club planning, operations, event production, entertainer bookings, and sponsorship services. The event curation segment produces both in-house and client events; the sub-leasing segment rents venues and sub-leases them to clubs; and the restaurants segment operates themed dining outlets that complement its entertainment offerings.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: